.
MergerLinks Header Logo

New Deal


Announced

Sarvapriya Healthcare Solutions to acquire a 42.36% stake in Dalmia Bharat Refractories from Dalmia Bharat Group for $97m.

Financials

Edit Data
Transaction Value£78m
Consideration TypeCash
Capital Owned-
Capital Bid For42%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Specialty Chemicals

Friendly

Private

Domestic

refractories

Single Bidder

Pending

Acquisition

Minority

India

Synopsis

Edit

Sarvapriya Healthcare Solutions, a holding company, agreed to acquire a 42.36% stake in Dalmia Bharat Refractories, a refractories manufacturer, from Dalmia Bharat Group, a cement group, for $97m. “In line with its strategy to exit non-core business/investment and pursuant to the approval granted by its Board of Directors in its meeting held on March 25, 2023, Dalmia Cement (Bharat), a material wholly owned subsidiary of the Company, has entered into a binding agreement to sell its entire investment of 18m equity Shares of Rs. 10 each (42.36% of share capital) of Dalmia Bharat Refractories Limited (DBRL), an associate company, at a consideration of Rs. 800 cr. to M/s Sarvapriya Healthcare Solutions Private Limited (Sarvapriya), a promoter group Company.” Dalmia Bharat.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US